Open Access. Powered by Scholars. Published by Universities.®
Translational Medical Research
COVID-19; Post-Acute COVID-19 Syndrome; PACS Post COVID-19 Syndrome; Medications; Polypharmacy; Multi-Morbidity; Older Adults
Articles 1 - 1 of 1
Full-Text Articles in Epidemiology
Post-Acute Sequelae Of Covid-19 And Polypharmacy: If You Think There’S Too Much Polypharmacy Now, Just Wait, Demetra Antimisiaris
Post-Acute Sequelae Of Covid-19 And Polypharmacy: If You Think There’S Too Much Polypharmacy Now, Just Wait, Demetra Antimisiaris
The University of Louisville Journal of Respiratory Infections
The intersection of increased chronic disease burden worldwide with the COVID-19 pandemic was called the “perfect storm”. This article discusses yet another perfect storm: Post COVID-19 (acute and non-acute) syndrome, high chronic disease burdens, advanced age, and polypharmacy. The expected hyper polypharmacy that should result from the added disease and symptom burden due to post COVID-19 syndrome is discussed, as well as the importance of studying the incidence and characteristics to be able to address avoidable medication-related problems.